AYTU BioPharma
AYTU
42 hedge funds and large institutions have $1.65M invested in AYTU BioPharma in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 1 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 1
40% more funds holding
Funds holding: 30 → 42 (+12)
0.24% more ownership
Funds ownership: 0.47% → 0.71% (+0.24%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
34% less capital invested
Capital invested by funds: $2.5M → $1.65M (-$855K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$569K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$479K |
| 3 |
Renaissance Technologies
New York
|
+$262K |
| 4 |
Walleye Capital
New York
|
+$221K |
| 5 |
AC
Ayrton Capital
Westport,
Connecticut
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$44.8K |
| 2 |
D.E. Shaw & Co
New York
|
-$13K |
| 3 |
Two Sigma Investments
New York
|
-$5.49K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.01K |
| 5 |
Morgan Stanley
New York
|
-$1.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| $4K | +$7.78K | +1,026 | New |
|
27
Jane Street
New York
| $3K | +$5.14K | +677 | New |
|
|
SPC
28
Sigma Planning Corp
Ann Arbor,
Michigan
| $3K | +$6.45K | +850 | New |
|
29
Bank of New York Mellon
New York
| $2K | – | – | – |
|
|
HAIM
30
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
ACA
31
Affinity Capital Advisors
Berkeley,
California
| $2K | +$4.33K | +571 | New |
|
32
Fidelity Investments
Boston,
Massachusetts
| $2K | +$4.55K | +600 | New |
|
33
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | -$357 | -47 | -14% |
|
34
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
35
BNP Paribas Financial Markets
Paris,
France
| $97 | +$197 | +26 | New |
|
|
36
D.E. Shaw & Co
New York
| – | -$13K | -912 | Closed |
|
37
Simplex Trading
Chicago,
Illinois
| – | -$190 | -25 | -11% |
|
38
Bank of America
Charlotte,
North Carolina
| – | -$38 | -5 | -8% |
|
39
Wells Fargo
San Francisco,
California
| – | +$76 | +10 | +7% |
|
|
FWM
40
Focused Wealth Management
Newburgh,
New York
| – | +$379 | +50 | +500% |
|
AYTU Hedge Fund Activity: Q3 2022 in Review
42 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q3 2022, worth a combined $1.65M — down 34% from $2.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AYTU positions and 1 closed out — a net gain of 12 holders — while 9 added to existing stakes and 10 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $569K. The largest seller was Vanguard Group, cutting an estimated $44.8K.
- 42 institutional investors held AYTU BioPharma (AYTU) as of Q3 2022, up from 30 in Q2 2022.
- Funds reported $1.65M of AYTU BioPharma stock for Q3 2022, down 34% quarter-over-quarter.
- 13 funds opened new AYTU BioPharma positions in Q3 2022 and 1 closed out, a net change of +12 holders.
- The largest AYTU BioPharma buyer in Q3 2022 was Alyeska Investment Group, an estimated $569K added.
- The largest AYTU BioPharma seller in Q3 2022 was Vanguard Group, an estimated $44.8K sold.
Based on aggregated 13F filings for Q3 2022.